Clinical Trials Directory

Trials / Sponsors / Syndeio Biosciences, Inc

Syndeio Biosciences, Inc

Industry · 8 registered clinical trials — 2 currently recruiting.

StatusTrialPhaseStarted
RecruitingA Phase 2 Study of Zelquistinel or Placebo for the Reduction of Symptoms of Major Depressive Disorder
Major Depressive Disorder
Phase 22026-01-05
Active Not RecruitingPharmacokinetics of Zelquistinel in Fasted or Fed State
Healthy Volunteers in Fed and Fasted State
Phase 12025-07-24
RecruitingZelquistinel or Placebo for the Reduction of Symptoms of Major Depressive Disorder
Major Depressive Disorder
Phase 22025-02-03
CompletedMultiple Ascending Dose and Electroencephalography Trial of GATE-202 in Healthy Volunteers
Major Depressive Disorder
Phase 12022-10-15
TerminatedSafety and Tolerability of Single and Multiple Ascending Doses of GATE-101 in Normal Human Volunteers
Major Depressive Disorder, Excessive Sleepiness
Phase 12020-10-26
CompletedZelquistinel in the Treatment of Adults With Major Depressive Disorder
Major Depressive Disorder
Phase 1 / Phase 22018-11-08
CompletedZelquistinel in the Treatment of Major Depressive Disorder
Depressive Disorder, Major
Phase 22018-06-13
CompletedSafety and Tolerability of Zelquistinel in Normal Human Volunteers
Major Depressive Disorder
Phase 12016-12-09